Fellow Health Appoints Industry Executive Paul Kappelman as Independent Chairman of the Board

Feb 18, 2026

Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced that industry executive and private equity advisor Paul Kappelman has been appointed Independent Chairman of the Board. Mr. Kappelman brings more than 30 years of healthcare leadership experience, including deep expertise in fertility care, to support Fellow Health in its next phase of growth.

Mr. Kappelman previously served as Chief Executive Officer of Ovation Fertility, where he oversaw the company’s expansion and guided the organization through its acquisition by US Fertility. During his tenure, he focused on strengthening clinical operations and working closely with physicians to support long-term organizational performance.

Prior to Ovation, Mr. Kappelman held senior leadership roles across hospital systems and healthcare services organizations, including serving as Chief Operating Officer of Ardent Health Services and leading hospital operations at LHP Hospital Group. Earlier in his career, he served as a hospital CEO, including leading the development and launch of a new hospital from the ground up. He currently serves as a Senior Independent Operating Advisor to Morgan Stanley Capital Partners, where he works with healthcare management teams on growth strategy, governance, and execution.

“Paul has unmatched experience building and scaling healthcare organizations,” said Brian Hogan, CEO of Fellow Health. “As we continue to grow our network of more than 3,000 fertility and urology practices, his perspective as a former fertility CEO and board leader will be invaluable. We’re excited to welcome Paul as Chairman as we focus on scaling with intention, strengthening clinical partnerships, and expanding access to modern reproductive health solutions for men.”

“Fellow Health is addressing long-standing gaps in reproductive health by combining clinical rigor with a modern, patient-first model,” said Kappelman. “The company has built meaningful trust with providers by making care easier to deliver and easier for patients to complete. I’m excited to partner with the leadership team as they continue to expand access to their mail-in semen analysis kits.”

Mr. Kappelman holds a master’s degree in healthcare administration from Tulane University School of Public Health and Tropical Medicine.

Learn more about…

The Fellow Semen Analysis and Vasectomy Test kits

Fellow tests

Fellow tests

Fellow's mail-in tests support men at every stage of the reproductive journey.

Fellow's mail-in tests support men at every stage of the reproductive journey.

Fellow's validation paper showing the clinical accuracy of our method, alongside a study demonstrating that Fellow drives industry-leading compliance with post-vasectomy semen analysis.

The science behind our tests

The science behind our tests

Fellow testing was created and validated with leaders in men’s reproductive health, making our flagship semen analysis the only diagnostic-grade mail in test on the market

Fellow testing was created and validated with leaders in men’s reproductive health, making our flagship semen analysis the only diagnostic-grade mail in test on the market

Two professionals stand in front of a research poster presented by Fellow

Peer-reviewed research

Peer-reviewed research

With over 175,000 samples processed to date, we are moving reproductive health forward by powering novel, large-scale research.

With over 175,000 samples processed to date, we are moving reproductive health forward by powering novel, large-scale research.